Your browser is no longer supported. Please, upgrade your browser.
We’ve released a new Beta version of our Futures section! Try it now. We look forward to your feedback! ×
Johnson & Johnson
IndexDJIA S&P500 P/E17.81 EPS (ttm)5.59 Insider Own0.01% Shs Outstand2.78B Perf Week-2.43%
Market Cap276.89B Forward P/E15.45 EPS next Y6.45 Insider Trans-29.76% Shs Float2.78B Perf Month-1.85%
Income15.92B PEG3.47 EPS next Q1.70 Inst Own67.40% Short Float1.07% Perf Quarter-2.16%
Sales73.59B P/S3.76 EPS this Y18.50% Inst Trans-0.02% Short Ratio3.25 Perf Half Y2.77%
Book/sh24.68 P/B4.03 EPS next Y4.97% ROA15.50% Target Price109.10 Perf Year3.62%
Cash/sh11.90 P/C8.37 EPS next 5Y5.13% ROE27.40% 52W Range93.83 - 108.23 Perf YTD-4.11%
Dividend2.80 P/FCF- EPS past 5Y5.30% ROI18.40% 52W High-7.99% Beta0.58
Dividend %2.81% Quick Ratio2.00 Sales past 5Y3.70% Gross Margin69.30% 52W Low6.13% ATR1.31
Employees126500 Current Ratio2.40 Sales Q/Q-4.10% Oper. Margin30.10% RSI (14)46.15 Volatility0.98% 1.19%
OptionableYes Debt/Eq0.27 EPS Q/Q-6.70% Profit Margin28.10% Rel Volume1.21 Prev Close99.79
ShortableYes LT Debt/Eq0.22 EarningsApr 14 BMO Payout38.20% Avg Volume9.17M Price99.58
Recom2.50 SMA20-1.16% SMA50-1.00% SMA200-2.75% Volume11,069,333 Change-0.21%
Dec-08-14Reiterated RBC Capital Mkts Outperform $110 → $114
Jul-16-14Reiterated Deutsche Bank Hold $102 → $107
Apr-17-14Reiterated Argus Buy $104 → $116
Apr-16-14Reiterated RBC Capital Mkts Outperform $104 → $106
Jan-10-14Downgrade Barclays Overweight → Equal Weight $99
Jan-07-14Upgrade RBC Capital Mkts Sector Perform → Outperform $88 → $104
Dec-16-13Reiterated Deutsche Bank Hold $93 → $95
Jul-18-13Reiterated Argus Buy $96 → $104
Jul-17-13Reiterated Barclays Overweight $95 → $99
Jul-17-13Downgrade Deutsche Bank Buy → Hold $92 → $93
Apr-18-13Reiterated Argus Buy $80 → $96
Apr-15-13Reiterated Barclays Overweight $85 → $95
Apr-12-13Reiterated Deutsche Bank Buy $82 → $87
Mar-26-13Reiterated UBS Buy $81 → $87
Jan-11-13Reiterated UBS Buy $76 → $78
Jan-04-13Upgrade Deutsche Bank Hold → Buy $75 → $82
Nov-20-12Initiated Stifel Nicolaus Hold
Jul-18-12Reiterated RBC Capital Mkts Sector Perform $65 → $71
Apr-18-12Reiterated UBS Buy $71 → $70
Dec-12-11Reiterated UBS Buy $72 → $69
Apr-18-15 08:02AM  IBM Transition In Focus With Q1 Earnings at Investor's Business Daily
Apr-17-15 08:04PM  Hottest ETF Strategy: Factor Investing In Stocks at Investor's Business Daily
05:26PM  Johnson & Johnson's New Billion-Dollar Blockbuster at Investopedia
02:27PM  7 Dow Stocks Beat Earnings Estimates But Shares Slide Anyway at Forbes
11:02AM  Dow 30 Stock Roundup: GE Plans Restructuring, JPM, Goldman, UNH Beat Estimates - Analyst Blog
10:09AM  Maverick Capital Increases Stake in Novartis
09:40AM  Weight Watchers (WTW) Horrid Q1 Not Enough to Stop North Tide Capital From Double Digit Returns at Insider Monkey
03:05AM  Heres what CEOs said about the economy this week
Apr-16-15 04:01PM  The 4 Stocks That Weighed on the DJIA Thursday at 24/7 Wall St.
10:50AM  Receptos MS Drug Succeeds Against Ulcerative Colitis at Investor's Business Daily
10:05AM  5 Must-See Stock Charts to Trade for Gains at TheStreet
08:30AM  Healthcare ETFs in Focus Post JNJ Earnings Beat - ETF News And Commentary
Apr-15-15 07:51PM  Contact lens makers sue Utah over anti-price fixing law
07:16PM  Are J&J's Results a Harbinger of Things to Come? at Investopedia
06:16PM  Robots In Our Homes And In Our Personal Lives at Forbes
05:43PM  4 ways a surging dollar rattles world economies, markets AP
04:21PM  J&J Earnings Analysis: By the Numbers
03:43PM  Bank Of America Sees Big Divestitures Upcoming For Johnson & Johnson
01:57PM  Biotech IPOs Ignite As Aduro Doubles On First Day at Investor's Business Daily
01:56PM  TechBits: Analyzing medical data, breaking smartphones
01:33PM  AQR Capital Trades Key Positions in its 4Q14 Portfolio
12:15PM  Will Health Tech Really Make Us Healthier? at Fox Business
11:12AM  Johnson & Johnson Trends Favor Four Stocks at
11:10AM  Correction: Financial Markets story
11:01AM  Strong dollar hits J&J
10:52AM  3 Biotech Stocks Under $10 with Amazing Growth Prospects - Analyst Blog
10:10AM  Stock Market News for April 15, 2015 - Market News
10:03AM  US Stock Market up 0.19% WFC, JPM, and JNJ Beat Estimates
09:29AM  Cramer: Transports could be leaders
09:22AM  Why the Strong Dollar Hurts Investors and What They Should Do About it at Money
08:30AM  More Financials In Focus As Market Scours For Signals at Investor's Business Daily
08:00AM  Pruning Pricey Stocks From Your Portfolio at Kiplinger
01:15AM  Aduro Biotech hits 'unicorn' exit with upsized $119M IPO at
12:04AM  J&Js Drug Treatment for the Dollar at The Wall Street Journal
12:03AM  [$$] J&Js Profit Falls on Strong Dollar, Weak Medical-Device Sales at The Wall Street Journal
Apr-14-15 07:33PM  Cramer Remix: This company's worth double at CNBC
07:16PM  An Apple Watch A Day & IBM To Keep Doctor Away? at Investor's Business Daily
06:46PM  How Will IBM's New Watson Health Unit Work?
06:23PM  Aduro IPO pricing values drugmaker at $1 bln Reuters
06:12PM  Cramer: Big market positives that can't be ignored at CNBC
05:48PM  J&J Earnings Beat Estimates; Guidance Mixed at Investor's Business Daily
05:46PM  Aduro Biotech IPO priced at $17 per share - underwriter Reuters
05:30PM  Stocks End Mostly Higher After Earnings, Data
05:16PM  Johnson & Johnson and IBM Announce Plans to Collaborate on Advanced Solutions Designed to Transform Healthcare Delivery at noodls
05:08PM  Johnson & Johnson and IBM Announce Plans to Collaborate on Advanced Solutions Designed to Transform Healthcare Delivery at noodls
04:54PM  US stocks mostly higher after rise in oil, mixed earnings
04:20PM  Lackluster Rebound in U.S. Sales Shows Consumers Hesitant
04:16PM  Johnson & Johnson, Pfizer and Zimmer Holdings are Top Stock Picks at TheStreet
04:14PM  Rep. Renee Ellmers Signals Support of Revised Abortion Ban Bill at Bloomberg
03:19PM  Four trades to go before Tuesday's close at CNBC
03:16PM  US stocks mostly higher following mixed profit reports
03:12PM  IBM Watson Health to hire hundreds for new Boston-area HQ at
03:09PM  J&J cuts full-year forecast due to strong dollar
03:05PM  IBM Launches Watson Health Unit, Buys Health Tech Startups - Analyst Blog
02:58PM  J&J's Drug Treatment for the Dollar at The Wall Street Journal
01:59PM  Johnson And Johnson (JNJ) Earnings Report: Q1 2015 Conference Call Transcript at TheStreet
01:58PM  IBMs Watson Brings Health Care Technology to the Cloud at Bloomberg
01:26PM  US STOCKS-Wall Street moves higher, led by energy shares
01:25PM  US stocks up in afternoon trading on mixed profit reports
01:00PM  Headwinds Still Blowing on J.P. Morgan at Morningstar
12:58PM  Top trades for the 2nd half: JNJ, JBHT, GS
12:53PM  Dollar and Treasury yields slide as US data disappoint at Financial Times
12:50PM  J&J cuts guidance as strong dollar hits sales at Financial Times
12:00PM  Stocks Choppy After Earnings, Data
11:58AM  Johnson & Johnson, Pfizer Good Stock Buys in Pricey Market at TheStreet
11:55AM  Stocks waver in noon trading after mixed earnings reports
11:34AM  US STOCKS-Wall St turns lower as earnings concerns linger
11:22AM  Stocks are all over the place
11:18AM  Stocks waver in morning trade after mixed earnings reports
11:13AM  Johnson & Johnson beats Street 1Q forecasts
11:12AM  J&J Earnings Beat Estimates; Guidance Mixed at Investor's Business Daily
11:06AM  Lone Pine Capital Sells Its Stake in Actavis
10:47AM  Apple and IBM take on health care data with Watson at CNBC
10:45AM  J&J: playing patience at Financial Times
10:45AM  J&J Beats on Q1 Earnings, Cuts View on Currency Woes - Analyst Blog
10:39AM  IBM takes medical data to the cloud
10:27AM  Dow turns lower despite JPM gains; earnings, data eyed at CNBC
10:25AM  Dont look in the Rearview Mirror
10:24AM  US stocks fall in early trading after mixed earnings reports
10:18AM  Caution: Slowing Growth Ahead for J&J at Morningstar
10:12AM  Johnson & Johnson results: the dollar and law of round numbers
10:11AM  US STOCKS-Wall St edges up after JPMorgan, J&J results
09:57AM  Egypts Education Minister Slams Cairo School-Yard Book Burning at Bloomberg
09:40AM  Stocks open higher as earnings come in; JPMorgan gains
09:37AM  Dow nears session highs
09:14AM  Morning Movers: JPMorgan Gains on Earnings Beat; JC Penney Slips at
09:10AM  JPMorgan and Wells Fargo top estimates; Nokia/Alcatel-Lucent in talks
09:05AM  US STOCKS-Futures point to flat open after JPMorgan, J&J results
08:55AM  Why it may be time to start believing in banks again at MarketWatch
08:55AM  Stocks Set For Soft Start; JPMorgan, Wells Fargo Top Views at Investor's Business Daily
08:55AM  Cramer: JPM's 'making so much money'
08:53AM  Strong Dollar Remains Headache For Johnson & Johnson at Forbes
08:45AM  Johnson & Johnson Slices Forecast as Strong Dollar Hits Revenues at 24/7 Wall St.
08:40AM  J&J earnings beat despite THIS factor at CNBC
08:37AM  Johnson & Johnson (JNJ) Stock Climbing Today on Better Than Expected First Quarter Earnings at TheStreet
08:32AM  April 14 Premarket Briefing: 10 Things You Should Know
08:30AM  Wholesale Prices in U.S. Increase for First Time in Five Months
08:26AM  Johnson & Johnson Reports 2015 First-Quarter Results: at noodls
08:25AM  JOHNSON & JOHNSON Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit
08:24AM  J&J's Profits Fall as Dollar Rises at The Wall Street Journal
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand name; oral care products under the LISTERINE brand name; skin care products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, LUBRIDERM, NEUTROGENA, and RoC brand names; women's health products, such as sanitary pads under the STAYFREE and CAREFREE, and o.b. tampon brand names; wound care products, including adhesive bandages and first aid products under the BAND-AID and NEOSPORIN brand names; and nutritional products comprising no calorie sweetener under the SPLENDA brand name. This segment also offers over-the-counter medicines, including acetaminophen products under the TYLENOL brand name; cold, flu, and allergy products under the SUDAFED brand name; allergy products under the BENADRYL and ZYRTEC brand names; ibuprofen products under the MOTRIN IB brand name; and heartburn products under the PEPCID brand name. The Pharmaceutical segment provides various products in the areas of immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment offers orthopaedic, and trauma and neurological products; general surgery, and biosurgical and energy products; products to treat cardiovascular disease; infection prevention products; diagnostics products; blood glucose monitoring and insulin delivery products; and disposable contact lenses. The company distributes its products to general public, retail outlets and distributors, wholesalers, hospitals, and health care professionals for prescription use in the professional fields by physicians, nurses, hospitals, and clinics. Johnson & Johnson was founded in 1885 and is based in New Brunswick, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fasolo PeterVP, Global Human ResourcesMar 05Option Exercise65.37115,3077,537,619147,895Mar 09 05:14 PM
Fasolo PeterVP, Global Human ResourcesMar 05Sale102.40115,30711,807,86332,588Mar 09 05:14 PM
Stoffels PaulusChief Scientific OfficerFeb 09Option Exercise0.0029,073064,647Feb 11 08:16 PM
Caruso Dominic JVP, Finance; CFOFeb 09Option Exercise0.0031,5370101,324Feb 11 08:16 PM
Fasolo PeterVP, Global Human ResourcesFeb 09Option Exercise0.0020,935042,109Feb 11 08:16 PM
Gorsky AlexChairman, CEOFeb 09Option Exercise0.0042,1120130,173Feb 11 08:17 PM
COSGROVE STEPHEN JCorporate ControllerJan 16Option Exercise0.0011,1080101,402Jan 21 05:48 PM
Ullmann Michael HVP, General CounselJan 16Option Exercise0.008,949075,628Jan 21 05:48 PM
Caruso Dominic JVP, Finance; CFOJan 16Option Exercise0.0012,615074,216Jan 21 05:48 PM
Gorsky AlexChairman, CEOJan 16Option Exercise0.0016,845094,425Jan 21 05:48 PM
Stoffels PaulusChief Scientific OfficerJan 16Option Exercise0.0011,629039,539Jan 21 05:48 PM
Fasolo PeterVP, Global Human ResourcesJan 16Option Exercise0.008,374024,336Jan 21 05:48 PM
PETERSON SANDRA EGroup Worldwide ChairmanDec 17Option Exercise0.0021,689031,210Dec 19 04:37 PM
JOHNSON & JOHNSON10% OwnerNov 12Buy18.0040,000720,0003,077,005Nov 12 03:06 PM
COSGROVE STEPHEN JCorporate ControllerNov 05Option Exercise66.182,490164,78892,784Nov 07 04:49 PM
COSGROVE STEPHEN JCorporate ControllerNov 05Sale108.552,490270,29390,294Nov 07 04:49 PM
CULLEN JAMESDirectorSep 10Sale104.122,446254,6721,489Sep 11 02:19 PM
Caruso Dominic JVP, Finance; CFOAug 21Option Exercise66.1830,0001,985,40091,600Aug 25 04:35 PM
Caruso Dominic JVP, Finance; CFOAug 21Sale104.3030,0003,129,06961,600Aug 25 04:35 PM
COSGROVE STEPHEN JCorporate ControllerMay 05Option Exercise66.1822,0001,455,960112,294May 06 06:10 PM
COSGROVE STEPHEN JCorporate ControllerMay 05Sale100.0522,0002,201,10090,294May 06 06:10 PM
JOHNSON & JOHNSON10% OwnerMay 01Option Exercise5.1672,690375,0801,773,730May 05 02:19 PM
COSGROVE STEPHEN JCorporate ControllerApr 25Option Exercise66.181,51099,93291,293Apr 28 05:03 PM